Medindia

X

Morningstar and NYSSA to Host Healthcare Conference in New York on March 4

Friday, February 12, 2010 General News J E 4
Advertisement
CHICAGO, Feb. 11 Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investment research, and the New York Society of Security Analysts (NYSSA) will hold their first Healthcare Conference in New York City on March 4, 2010. Morningstar equity analysts and healthcare industry executives will come together to discuss the outlook for the industry.

"Our first healthcare conference is an opportunity to bring institutional investors and analysts together with healthcare industry leaders to explore long-term investment opportunities in the sector, including pharmaceutical, biotechnology, medical devices, and healthcare services," said Damien Conover, equities strategist and editor of Morningstar Healthcare Observer. "We want to answer questions that are top of mind for investors looking at the healthcare sector, from the expected effect of U.S. healthcare reform to the outlook for mergers and acquisitions in this space."

Healthcare executives who will present at the conference include:

Morningstar's healthcare equity analysts will also present on timely topics including their outlook for the healthcare sector in 2010, prospects for merger-and-acquisition activity, and the paradigm shift in drug development for niche diseases.

For more information, please visit: http://www.nyssa.org/AM/Template.cfm?Section=calendar&template=/CM/ContentDisplay.cfm&ContentID=15446.

Attendee Registration Information

Registration for the Morningstar/NYSSA Healthcare Conference is $50 for NYSSA members and $75 for non-NYSSA members. To register, please visit: http://www.nyssa.org/AM/Template.cfm?Section=calendar&template=/CM/ContentDisplay.cfm&ContentID=15446. Attendees can obtain one hour of continuing education (CE) credits as granted by the Certified Financial Planner Board of Standards, Inc.

Complimentary Registration for Journalists

Members of the news media may receive complimentary registration to the Morningstar/NYSSA Healthcare Conference by contacting Nadine Youssef, Morningstar corporate communications, at 312-696-6601 or nadine.youssef@morningstar.com.

About Morningstar, Inc.

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offers an extensive line of Internet, software, and print-based products and services for individuals, financial advisors, and institutions. Morningstar provides data on more than 325,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 4 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. The company has operations in 20 countries and minority ownership positions in companies based in two other countries.

This press release is not intended to be an offer or solicitation to buy or sell the above-mentioned securities. Under Morningstar's editorial policies, equity analysts are prohibited from holding positions in the companies they cover.

About NYSSA

The New York Society of Security Analysts (NYSSA) is a leading forum for the investment community. NYSSA's mission is to promote best practices and the highest professional and ethical standards in the industry. With over 10,000 members, NYSSA is the largest of the more than 136 societies worldwide that make up CFA Institute, which has more than 94,000 members.

Đ2010 Morningstar, Inc. All rights reserved.

MORN-C

-- Vincent A. Forlenza, president, Becton, Dickinson and Company (BDX) -- Coleman N. Lannum, CFA, vice president, Covidien (COV) -- Nachum Shamir, president and CEO, Given Imaging Ltd. (GIVN) -- Dr. Paul Chew, senior vice president, U.S. chief science officer/chief medical officer, sanofi-aventis (SNY) -- John Ornell, chief financial officer, Waters Corporation (WAT)

SOURCE Morningstar, Inc.
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
Endologix to Report Fourth Quarter and Full Year 2...
S
Deloitte Debate: Merge Fast, or is Patience a True...